Clinical Insights
Feature Article
Filling the Therapeutic Gap in Herniated Disc Treatment: Inconsistencies in Diagnosis and Treatment Between Failed Conservative Care and Surgery.
Back pain is the #1 source of workdays lost to disability globally[1], with approximately 80% of adults experiencing a herniated disc in their lifetime[2] and an estimated prevalence of symptomatic herniated discs of 1-3% of patients[3]. The pain, loss of productivity, and related mental health deterioration resulting from chronic pain
Collected Literature
Intradiscal Oxygen-Ozone Non-Inferior to Microdiscectomy at 6 Months
71% of patients avoided surgery. Non-inferior to microdiscectomy surgery.
2,597 patient Systematic Review – Intradiscal Oxygen-Ozone Safe and Effective
9 superior, 3 equivalent to control, 3 not assessed.
8,000 patient Meta Analysis: 62.5-86% effective, 0.6% adverse event rate
62.5-85% in terms of leg pain relief.
The likelihood of showing improvement on the modified MacNab
scale was 79.7%.
Intradiscal Oxygen-Ozone 82%/88% effective over 5/10 years
75% of patients were able to avoid surgery, and of the patients that avoided surgery, 82% improved at 5 years, and 88% improved at 10 years. 79% of patients had a reduction in herniation volume and the average reduction was 56%.
Intradiscal Oxygen-Ozone Superior to ESI Injections at 12 Months
Prospective, double blind, RCT; Ozone + ESI vs ESI alone.
1,750 Patients Show Intradiscal Oxygen-Ozone 80%/75% Effective at 6mo/18mo
80% success rate and 20% failure rate in 1750 patients followed up to 6 months. Success dropped to 75% and failure increased at 25% in 1400 followed up to 18 months.
The Mission: Field Research
This page shares SpinaFX’s ongoing field research initiative with physicians from across Canada. We seek and share physician opinions, perspectives, and scientific exchange related to diagnosis, treatment, and follow-up on low back pain. Specifically, we are eliciting your experience and evidence related to:
- Pros & cons for providers and patients in Canada
- Your gold-standard treatments?
- Gaps in care between conservative therapy and surgery?
- Opioids, wait-times, adverse-event rates?
- Innovations; what’s on the horizon and do you expect them to meet your therapeutic needs?